A randomized, double-Blind, parallel-group, placebo-controlled study in patients with symptomatic overactive bladder.
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 10 Mar 2009 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 10 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.